Remarkably, CD90+ CXCL12+ CAFs were found to protect BPH-1 cells against hydrogen peroxide induced apoptosis in vitro, suggesting that CD90+ CAFs may promote prostate epithelial cell survival [77]. Here, THY1 is linked to benign prostatic hyperplasia.